SLG
CC icon

Stanley-Laman Group’s Chemours CC Stock Holding History

Stanley-Laman Group’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-13,976
Closed -$98K – 266
2016
Q1 		$98K Buy
13,976
+3,731
+36% +$18.7K 0.02% 281
2015
Q4 		$55K Buy
+10,245
New +$65.5K 0.01% 347

Other funds holding CC

GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GCM
Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Stanley-Laman Group's CC Position: Q2 2016 in Review

Stanley-Laman Group sold out of Chemours (CC) in Q2 2016, closing a stake of 13,976 shares — an estimated $98K sold.

Stanley-Laman Group first reported a position in CC in Q4 2015 and held it in 2 quarters. The position peaked at $98K in Q1 2016. 372 funds tracked by Wall St. Rank hold CC as of Q2 2016.

  • Stanley-Laman Group reported no remaining Chemours position as of Q2 2016 after selling out during the quarter.
  • Stanley-Laman Group sold 13,976 Chemours shares in Q2 2016, an estimated $98K.
  • Stanley-Laman Group first reported a position in Chemours in Q4 2015 and held it in 2 quarters.
  • Stanley-Laman Group's Chemours position peaked at $98K in Q1 2016.
  • 372 funds tracked by Wall St. Rank held Chemours as of Q2 2016.

Based on Stanley-Laman Group's 13F filing for Q2 2016, filed 4 Aug 2016.